Preview

Tuberculosis and Lung Diseases

Advanced search

Effectiveness of Treatment of Rifampicin-Susceptible Tuberculosis in Coal Workers in Kemerovo Oblast

https://doi.org/10.58838/2075-1230-2025-103-5-16-23

Abstract

The objective: to investigate influence of the factor of employment in the coal industry with potential exposure to coal dust on the treatment outcomes of patients with rifampicin-susceptible tuberculosis.

Subjects and Methods. A retrospective cohort study was aimed to investigate treatment outcomes of rifampicin-susceptible tuberculosis (TB) in men residing in a coal-mining region of the Russian Federation. Information from the following registration forms was used: Notification of New Cases of Relapse of Tuberculosis (Extended Form 089/u and Medical Treatment Record TB-01/u). Patients were randomized in two groups: male workers of the coal industry (n=287) and a comparison group – other working men aged 21 to 60 years (n=1644) from this region.

Results. The hypothesis about influence of work in hazardous conditions (inhalation of fibrogenic silicon-containing coal dust) in the period preceding the disease on the effectiveness of tuberculosis treatment was found to be untenable after comparison to individuals who had no occupational hazards. The structure of outcomes of chemotherapy for respiratory tuberculosis in workers of the coal industry most likely working in mines, differed from that in Comparison Group by a lower frequency of individuals interrupting treatment (χ2=14.463; p=0.006). The high adherence to tuberculosis treatment among coal industry workers is likely due to the high skill requirements in the industry and their desire to return to work after completing chemotherapy. Thus, it has been proven that work in the coal industry with well-developed labor and social legislation does not relate to risk factors of an unfavorable outcome and poor treatment effectiveness in the patients with rifampicin-susceptible tuberculosis.

About the Authors

V. N. Zimina
Kemerovo State Medical University, Russian Ministry of Health; National Medical Research Center of Phthisiopulmonology and Infectious Diseases, Russian Ministry of Health
Russian Federation

Vera N. Zimina - Doctor of Medical Sciences, Professor of Phthisiology Department, Leading Researcher of Infectious Diseases Department, National Medical Research Center of Phthisiopulmonology and Infectious Diseases, Russian Ministry of Health.

22a Voroshilova St., Kemerovo, 650056

Phone: +7 (3842) 73-28-39



T. V. Pyanzova
Kemerovo State Medical University, Russian Ministry of Health
Russian Federation

Tatiana V. Pyanzova - Doctor of Medical Sciences, Associate Professor, Head of Phthisiology Department.

22a Voroshilova St., Kemerovo, 650056

Phone: +7 (3842) 73-28-39



S. A. Sterlikov
National Medical Research Center of Phthisiopulmonology and Infectious Diseases, Russian Ministry of Health; Russian Medical Academy of On-going Professional Education, Russian Ministry of Health
Russian Federation

Sergey A. Sterlikov - Doctor of Medical Sciences, Head of Department for Tuberculosis and HIV Epidemiology and Monitoring, Associate Professor of Department of Medical Statistics and Digital Health Care, Russian Medical Academy of On-going Professional Education, Russian Ministry of Health.

Build. 2, 4 Dostoevskiy St., Moscow, 127473

Phone: +7 (495) 631-15-15



I. B. Viktorova
Novokuznetsk State Institute for Doctors' Professional Development - Branch of Russian Medical Academy of On-going Professional Education, Russian Ministry of Health
Russian Federation

Irina B. Viktorova - Doctor of Medical Sciences, Professor of Phthisiopulmonology Department.

5 Stroiteley Ave., Novokuznetsk, Kemerovo Region, 654005

Phone: + 7 (3843) 45-48-73



K. V. Sibil
I.F. Kopylova Kuzbass Clinical Phthisiopulmonary Medical Center
Russian Federation

Kirill V. Sibil - Candidate of Medical Sciences, Head Physician.

5 Khimikov Ave., Kemerovo, Russia, 650036

Phone: + 7 (3842) 54-46-09



I. A. Vasilyeva
National Medical Research Center of Phthisiopulmonology and Infectious Diseases, Russian Ministry of Health; Pirogov Russian National Research Medical University, Russian Ministry of Health
Russian Federation

Irina A. Vasilyeva - Doctor of Medical Sciences, Professor, Director, Head of Phthisiology Department, Pirogov Russian National Research Medical University, Russian Ministry of Health.

Build. 2, 4 Dostoevskiy St., Moscow, 127473

Phone: +7 (495) 631-15-15



References

1. Bondarev O.I., Filimonov S.N. Systemic lesions of lung tissue elements of pneumoconiosis in Kuzbass miners. Meditsina v Kuzbasse, 2023, no. 3, pp. 49-55. (In Russ.)

2. Kobylkin S.S., Timchenko A.N. Classification of dust reduction systems in the mining works. MIAB. Mining Inf. Anal. Bull., 2021, no. 10-11, pp. 112-123. (In Russ.) https://doi.org/10.25018/0236_1493_2021_101_0_112

3. Kornev A.V., Ledyaev N.V., Kabanov E.I., Korneva M.V. Estimation of predictive dust content in the faces of coal mines taking into account the peculiarities of the wettability of coal dust. MIAB. Mining Inf. Anal. Bull., 2022, no. 6-2, pp. 115-134. (In Russ.) https://doi.org/10.25018/0236_1493_2022_62_0_115

4. Edict no. 341n by the Russian Ministry of Labor as of August 02, 2013 (Version as of February 20, 2014) On Approval of Standard for Free Provision of Special Clothing, Special Footwear and Other Personal Protective Means to Workers in Operating and under Construction Mines, Open Pits and Organizations in Coal and Shale Industry, Engaged in Work in Harmful and (or) Hazardous Working Conditions, as well as Work Performed in Special Temperature Conditions or Associated with Pollution. (In Russ.) Available: https://base.garant.ru/70442050/?ysclid=matp1bz061977328782 Accessed May 18, 2025.

5. Saenko S.S. Sovershenstvovaniye organizatsii lecheniya bolnykh tuberkulezom v sovremennykh usloviyakh. Dis. kand. med. nauk. [Improvement of organization of treatment of tuberculosis patients under current conditions. Cand. Diss.]. Moscow, 2021, 227 p.

6. Sterlikov S.A., Galkin V.B., Maliev B.M., Shirokova A.A., Khorotetto V.A., Mayzhegisheva A.S. Impact of active case finding on treatment outcomes in adult pulmonary tuberculosis patients. Tuberculosis and Lung Diseases, 2021, vol. 99, no. 7, pp. 33-40. (In Russ.) https://doi.org/10.21292/2075-1230-2021-99-7-33-40

7. Federal Law no. 77-FZ as of June 18, 2001 (Version as of December 05, 2022) On Tuberculosis Transmission Prevention in the Russian Federation. (In Russ.) Available: https://base.garant.ru/12123352/?ysclid=matp3l8k3y382612105 Accessed September 27, 2025

8. Belilovsky E.M., Borisov S.E., Cook E.F., Shaykevichc S., Jakubowiak W.M., Kourbatova E.V. Treatment interruptions among patients with tuberculosis in Russian TB hospitals. International Journal of Infectious Diseases, 2010, vol. 14, no. 8, pp. 698-703. https://doi.org/10.1016/j.ijid.2010.03.001

9. Cowie R.L., Langton M.E., Becklake M.R. Pulmonary tuberculosis in South African gold miners. Am. Rev. Respir. Dis., 1989, no. 139, pp. 1086-1089. https://doi.org/10.1164/ajrccm/139.5.1086

10. Howlett P., Said B., Mwanga E., Mbuya A., Nota M., Kon O.M., Gottesfeld P., Feary J., Mpagama S., Ehrlich R. Confronting the growing epidemic of silicosis and tuberculosis among small-scale miners. Lancet Public Health, 2025, vol. 10, no. 4, pp. e343-e346.

11. Jamshidi P., Danaei B., Arbabi M., Mohammadzadeh B., Khelghati F., Akbari Aghababa A., Nayebzade A., Shahidi Bonjar A.H., Centis R., Sotgiu G., Nasiri M.J., Migliori G.B. Silicosis and tuberculosis: A systematic review and meta-analysis. Pulmonology, 2025, vol. 31, no. 1, pp. 2416791. https://doi.org/10.1016/j.pulmoe.2023.05.001

12. Jin Y., Fan J.G., Pang J., Wen K., Zhang P.Y., Wang H.Q., Li T. Risk of active pulmonary tuberculosis among patients with coal workers’ pneumoconiosis: a case-control study in China. Biomed. Environ. Sci., 2018, vol. 31, no. 6, pp. 448-453. https://doi.org/10.3967/bes2018.058

13. Khemakhem R., Moussa N., Kotti A., Feki W., Mnif Z., Feki W., Kammoun S. Accelerated silicosis and silico-tuberculosis: A difficult diagnosis // Clin Case Rep. – 2022. – Vol. 10, № 2. – Р. е05482. https://doi.org/10.1002/ccr3.5482

14. Lesnic E., Niguleanu A., Ciobanu S., Todoriko L. Predictive factors associated to low tuberculosis treatment outcome: cross sectional study // The Moldovan Medical Journal. – 2017. – Vol. 60, № 2. – Р. 7-12. https://doi.org/10.5281/zenodo.1050982

15. Litvinjenko S., Magwood O., Wu S., Wei X. Burden of tuberculosis among vulnerable populations worldwide: an overview of systematic reviews // Lancet Infect Dis. – 2023. – Vol. 23, № 12. – Р. 1395-1407. https://doi.org/10.1016/S1473-3099(23)00372-9

16. Musaazi J., Kiragga A.N., Castelnuovo B., Kambugu A., Bradley J., Rehman A.M. Tuberculosis treatment success among rural and urban Ugandans living with HIV: a retrospective study // Public Health Action. – 2017. – Vol. 7, № 2. – Р.100-109. https://doi.org/10.5588/pha.16.0115

17. Ngozi A.I., Kingsley N.U. Tuberculosis treatment default in a large tertiary care hospital in urban Nigeria: Prevalence, trend, timing and predictors // Journal of Infection and Public Health. – 2012. – № 5. – Р. 340-345. https:// doi.org/10.1016/j.jiph.2012.06.002

18. Rajavel S., Raghav P., Gupta M.K., Muralidhar V. Silico-tuberculosis, silicosis and other respiratory morbidities among sandstone mine workers in Rajasthan – a cross-sectional study // PLoS One. – 2020. – Vol. 15, № 4. – Р. e0230574. https://doi.org/10.1371/journal.pone.0230574

19. Rupani M.P. Silicosis as a predictor of tuberculosis mortality and treatment failure and need for incorporation in differentiated TB care models in India // Arch Public Health. – 2023. – Vol. 81, № 1. – Р. 173. https://doi.org/10.1186/s13690-023-01189-x

20. Rupani M.P., Soundararajan S. Survival analysis shows tuberculosis patients with silicosis experience earlier mortality and need employer-led care models in occupational settings in India // Sci Rep. –2024.– Vol. 14, № 1. – Р. 28891. https://doi.org/10.1038/s41598-024-80367-5

21. Sahakyan S.V. Petrosyan V., Abrahamyan L. Diabetes mellitus and treatment outcomes of pulmonary tuberculosis: a cohort study // Springer Nature. – 2020. – № 65. – P. 37-43.

22. Sahakyan S.V. Petrosyan V., Abrahamyan L. Retrospective cohort study of lost to follow up predictors among TB patients in Yerevan, Armenia // European Journal of Public Health. – 2017. – Vol. 27, Suppl. 3. – Р. ckx187.692. https://doi.org/10.1093/eurpub/ckx187.692

23. Sharma N., Kundu D., Dhaked S., Das A. Silicosis and silicotuberculosis in India // Bull World Health Organ. – 2016. – Vol. 94, № 10. – Р. 777-778. https://doi.org/10.2471/BLT.15.163550

24. WHO consolidated guidelines on tuberculosis. Module 2: screening - systematic screening for tuberculosis disease. CC BY-NC-SA 3.0 IGO Available at: https://www.who.int/publications/i/item/9789240022676 [Accessed 10.05.2024].

25. Wohlleben J., Makhmudova M., Saidova F., Azamova S., Mergenthaler C., Verver S. Risk factors associated with loss to follow-up from tuberculosis treatment in Tajikistan: a case-control study // BMC Infect Dis. – 2017. – № 17. – Р. 543. https://doi.org/10.1186/s12879-017-2655-7


Review

For citations:


Zimina V.N., Pyanzova T.V., Sterlikov S.A., Viktorova I.B., Sibil K.V., Vasilyeva I.A. Effectiveness of Treatment of Rifampicin-Susceptible Tuberculosis in Coal Workers in Kemerovo Oblast. Tuberculosis and Lung Diseases. 2025;103(5):16-23. (In Russ.) https://doi.org/10.58838/2075-1230-2025-103-5-16-23

Views: 211


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2075-1230 (Print)
ISSN 2542-1506 (Online)